MaxQ AI is ushering in a new era of AI-augmented healthcare through medical diagnostic solutions that help empower physicians around the world to better prioritize and identify life-threatening conditions such as stroke and traumatic brain injury in acute care settings, which will save lives, improve the quality of care, and lower healthcare costs.
Our Mission
Our mission is to meaningfully reduce misdiagnosis and healthcare costs by making artificial intelligence intrinsic to the diagnostic process for time-sensitive and life-threatening conditions. When we’re successful, we’ll have elevated the global standard of acute medical care by providing universal access to expert diagnosis.
Our Focus
We are focused on building applications to enable doctors to reach faster, more accurate decisions when diagnosing stroke, traumatic brain injury, and other life-threatening conditions; and this is only the beginning. A new era is here. MaxQ AI is ushering in empowered care, the partnership between AI and the skilled caregiver to bring expert care to every patient.
Our Technology
Our products are based on artificial intelligence, deep learning, machine vision, and world-class clinical partners. We have developed software that uses artificial intelligence to interpret medical images such as non-contrast head computed tomography (CT) scans and surrounding patient data, for use in acute care settings. AI solutions are well-suited to help acute care physicians who are under extreme pressure to make quick and accurate decisions while treating a large number of patients.
Delivering A New Class Of Medial Diagnostic Artificial Intelligence, Striving To:
Enhance escalation and intervention confidence
Improve patient and staff experience
Deployed through major CT, AI ecosystem, and PACS channel partners
Potentially provide faster, better, smarter care
Provide the right care readied faster, improving quality to potentially avoid poor patient outcomes and to potentially decrease costs and liability
Every Patient Deserves Equal Access
To Expert Care
THE OPPORTUNITY - MISDIAGNOSIS
Johns Hopkins investigators have estimated that medical errors are the #3 cause of death in the U.S.12
The overall misdiagnosis rate in healthcare is estimated at 30 percent, and it can be as high as 50 percent in certain situations.21
This means that roughly 1 in 3, and often 1 in 2, patients may be misdiagnosed.12
To compound this issue further, the Association of American Medical Colleges recently predicted the nationwide shortage of providers will reach up to 121,000 physicians by 2032.18
Stroke And Traumatic Brain Injury
Every minute counts to ensure effective treatment and address the massive social and economic implications of brain damage.
The unfortunate reality is the sheer volume of traumatic brain injury and stroke cases admitted annually to an ED, whether it be a small or large facility, is not only growing but is also a source of diagnostic error.
The Future of AI
MAXQ AI SYMPOSIUM - AI FAD OR FOREVER
The CEO of MaxQ AI, Gene Saragnese, leads an intriguing symposium on the future of AI at the annual RSNA meeting in 2018. See a collection of highlights from the conversation and learn how technological development creates an impact on society.
ACCIPIO® Future
Diagnostic Rule Out
Provides diagnostic rule-out of suspected ICH (currently in development)
Accipio Ix™
Identification & Prioritization
click for demo
Provides Automatic, Rapid, Highly Accurate Identification and Prioritization
Accipio Ax™
Slice-level Annotation
click for demo
Provides Automatic, Rapid, Highly Accurate Slice-level Annotation & Prioritization
ACCIPIO®Future
Location & Volume Annotation
click for demo
Provides lesion-level annotation & quantification of lesion volume of suspected ICH (currently in development)
Channel Partners / Market Approach
More About ACCIPIO®
MaxQ AI will support the complete ACCIPIO® ICH and Stroke Platform with INSIGHT™: It will support the Radiology Department, Emergency Room, Neuroradiology and the Stroke teams with a fully-automated solution. The current ACCIPIO® platform provides tools for identification & prioritization (lx)1, slice-level annotation (Ax)2, and triage guidance for suspected ICH presence. The complete Accipio solution for head trauma and stroke promises to:
- Greatly increase ICH detection and reduce missed ICHs through near real-time triage, annotation and diagnostic rule-out – because every minute matters for TBI, trauma, and stroke patients
- Potentially enhance clinical confidence, including mobilization of ischemic stroke and neurosurgery teams
- Provide the right care readied faster, improving quality to potentially avoid poor patient outcomes and to decrease costs and liability
- Provide slice-level annotation, lesion-level annotation and quantification of lesion volume for suspected ICH
- Provide automatic diagnostic ICH rule-out
- Be deployed through Major CT, AI ecosystem, and PACS channel partners; completely integrated, supported, and serviced from partners you trust
- Address the total workflow needs of the reader. Not a single algorithm –– an ecosystem designed to benefit the patient, care provider, and facility
Testimonials
At MaxQ AI, we are dedicated to revolutionizing the acute care setting with innovative ai solutions. our ACCIPIO® platform is geared toward improving treatment for head trauma and stroke care patients, while also streamlining facility workflow and empowering healthcare professionals. read what customers are saying about us and see why we’re inspired every day to do what we do.
Key Takeaways
RISK
Today, there is immense pressure on the healthcare industry. With fewer resources, a shortage of healthcare providers, and more images to read than ever before, solutions are crucial.
At MaxQ AI, our mission is to meaningfully reduce misdiagnosis and healthcare costs by making artificial intelligence intrinsic to the diagnostic process for time-sensitive and life-threatening conditions. We are empowering “smarter care” through intelligent imaging with AI-driven actionable insights.
AI SOLUTIONS
MaxQ AI is at the cutting-edge of innovative Medical Diagnostic Artificial Intelligence. Our team of deep learning and machine vision experts develop innovative software that uses AI to interpret medical images and surrounding patient data.
We aspire to make a meaningful impact on stroke and brain trauma treatment across the world. We strive to help empower care providers with solutions to make faster, more accurate decisions.
EXPERTISE
Deployed through Major CT, AI ecosystem, and PACS channel partners; completely integrated, supported, and serviced from companies you trust.
Our partners distribute our on-premise and cloud-capable solution globally and include GE Healthcare, IBM Watson Healthcare, TeraRecon, Philips, and Samsung Neurologica.
REGULATIONS
We prioritize absolute rigor in all certifications, systems, and compliance to ensure the company behind the platforms leads by example.
- FDA Breakthrough Status, Class II FDA, Class IIb CE Mark
- ISO13485, FDA QSR, ISO14971, IEC62304, IEC62366 Standards Certified
- GDPR Compliant
- ISO 27001 BSI Certificate of Registration
- Supports HIPAA Compliance
- Data truthing by board-certified physicians